Health Care/Hospital
Fosun International Issues Positive Profit Alert: Profit Attributable to Owners of the Parent for 1H2026 Expected to be Approx. RMB 1.5 Billion to RMB1.8 Billion
HONG KONG, July 29, 2026 /PRNewswire/ -- On 29th July, Fosun International (00656.HK) issued a positive profit alert. Its profit attributable to owners of the parent for the first half of 2026 is expected to range from approximately RMB1.5 billion to RMB1.8 billion representing an increase of app...
2026-07-29 17:35
3591
Ping An Ranks 48th on 2026 Fortune Global 500 List, Marking 17th Consecutive Year on List
HONG KONG and SHANGHAI, July 29, 2026 /PRNewswire/ -- Ping An Insurance (Group) Company of China, Ltd. ("Ping An", the "Company" or the "Group"; HKEX: 2318; SSE: 601318) ranked No. 48 on the 2026 Fortune Global 500 list, released on July 28. The list ranks the world's largest corporations by reve...
2026-07-29 15:37
3379
Wellness Culture Gains Momentum Across Asia Pacific as 4 in 5 Consumers Prioritize Holistic Health - Herbalife Survey
HONG KONG, July 29, 2026 /PRNewswire/ -- Herbalife, a premier health and wellness company, community and platform, released findings from its latest survey, revealing a clear rise in a wellness culture - the modern phenomenon that emphasizes the active pursuit of holistic well-being through the ...
2026-07-29 11:00
4406
AbbVie Announces Availability of ELAHERE® (mirvetuximab soravtansine) in Singapore for the Treatment of Platinum-Resistant Ovarian Cancer
* ELAHERE is the first and only antibody-drug conjugate (ADC) therapy approved specifically for patients with folate receptor alpha (FRα) positive, platinum-resistant high grade serous epithelial ovarian cancer, fallopian tube or primary peritoneal cancer, who have received one to three prior s...
2026-07-29 10:00
2347
Australian medtech Navi raises $A6.8 million to commercialise breakthrough paediatric technology in the US
MELBOURNE, Australia and BOSTON, July 29, 2026 /PRNewswire/ -- Melbourne- and
Boston-based medical device company Navi Medical Technologies has closed a
$A6.8 million capital raise to commercialise its breakthrough paediatric
vascular access technology in the United States.
2026-07-29 08:00
2101
Ozelle Launches O-Cyte 1 at ADLM 2026, Marking a New Step in AI-Powered Hematology
The global launch brings image-based morphology intelligence into routine
hematology workflows through AI × CBM technology.
FRANKFURT, Germany and ANAHEIM, Calif., July 29, 2026 /PRNewswire/ -- Ozelle
2026-07-29 05:00
1716
IHH Healthcare Expands 'IHH Catalyst' to North Asia to Accelerate Clinical Adoption of Healthcare Innovation
Building on the success of its inaugural programme in India, IHH Healthcare is launching IHH Catalyst | North Asia Edition to help startups in Hong Kong, Chinese Mainland and neighbouring markets turn healthcare innovation into real-world clinical impact. HONG KONG and SINGAPORE and KUALA L...
2026-07-28 18:44
1495
Smartee Hosts Academic Programs in Thailand Highlighting Mandibular Repositioning Technology
BANGKOK, July 28, 2026 /PRNewswire/ -- Smartee Denti-Technology recently participated in two academic events in Bangkok, Thailand, focusing on the clinical principles and applications of its Mandibular Repositioning Technology. The programs brought together orthodontic professionals to exchange ...
2026-07-28 13:44
2534
New report identifies opportunities to help more patients in Asia Pacific benefit from advances in AFib care
Growing physician confidence in pulsed field ablation highlights the need to strengthen referral pathways, education and healthcare system readiness SINGAPORE, July 28, 2026 /PRNewswire/ -- Boston Scientific today revealed findings from a new report showing that, while physicians in Asia Pacific ...
2026-07-28 11:00
2391
The costly winter pet mistakes Australians are making
MELBOURNE, Australia, July 28, 2026 /PRNewswire/ -- As cost-of-living pressures
bite, Petstock is warning pet parents not to overlook subtle winter health
changes, which can lead to vet bills of up to $15,600 if left untreated.
2026-07-28 10:37
1407
Everest Medicines Announces Participation in Upcoming Investor Conferences
SHANGHAI, July 27, 2026 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today announced that Ian Woo, President and Chief Fi...
2026-07-27 23:17
1889
TriNetX Appoints August Calhoun Chief Executive Officer
Jeff Margolis Resumes Chairman Role as Company Completes CEO Transition CAMBRIDGE, Mass., July 27, 2026 /PRNewswire/ -- TriNetX, The Global Truth Engine for Better Human Health™ and operator of the world's leading federated health data network, today announced the appointment ofAugust Calhoun as ...
2026-07-27 23:00
1719
Seegene Proposes Comprehensive Reproductive Tract Infection Testing Approach through the Global Million Clinical Study (GMCS)
* STAgora™ analysis of approximately 60,000 test results collected over 42 months showed that STI pathogens were detected in 82% of HPV-positive cases * Findings support the potential value of a comprehensive testing approach that provides both HPV and STI pathogen information * Seegene to v...
2026-07-27 21:00
6001
Jyong Biotech Highlights Multi-Billion Dollar Global BPH Market Opportunity and Reaffirms Strategic Focus on Global Licensing Partnerships
TAIPEI, July 27, 2026 /PRNewswire/ -- Jyong Biotech Ltd. (Nasdaq: MENS) (the "Company" or "Jyong Biotech"), a science-driven biotechnology company dedicated to the development and commercialization of innovative plant-derived therapeutics,today reaffirmed its strategic focus on pursuing global li...
2026-07-27 20:20
1766
Waters Launches Industry's Most Sensitive and Robust Clinical IVD System with Xevo TQ Absolute XR IVD Mass Spectrometer
* Brings Xevo™ TQ Absolute XR Mass Spectrometer's industry-leading tandem quadrupole MS sensitivity to clinical applications across women's health, cancer assessment, and toxicology. * Offers 5x greater sensitivity vs. in-class instruments with lower detection limits in smaller sample volum...
2026-07-27 20:10
2119
Kelun-Biotech Receives a Clinical Trial Notice for Its First Dual-payload ADC SKB565
CHENGDU, China, July 27, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) today announced that it has received a clinical trial notice from the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA)...
2026-07-27 19:40
1745
Articura Launches a New Chapter for Sovereign Healthcare AI in Indonesia
Hospitals, clinics, academia and industry join a collaborative ecosystem designed to advance trusted, nationally grounded healthcare AI JAKARTA, Indonesia, July 27, 2026 /PRNewswire/ -- PT Articura Tech Indonesia ("Articura")today announced the foundation of its Sovereign Healthcare AI Platform,...
2026-07-27 19:02
12316
Ascletis Announces Once-Monthly Subcutaneously Administered GLP-1R/GIPR/GCGR Triple Peptide Agonist, ASC37, Demonstrated Superior Weight Loss in a Diet-Induced Obese Mouse Model
-ASC37 demonstrated statistically significant 88% greater relative body weight reduction compared to tirzepatide in the diet-induced obese (DIO) mouse model. -Both ASC37 once-monthly subcutaneous (SQ) formulation and oral formulation will be submitted to the U.S. Food and Drug Administration (FDA...
2026-07-27 18:42
1981
3Shape's TRIOS MOVE Pro Scanner Cart Wins Red Dot 2026 Design Award
COPENHAGEN, Denmark, July 27, 2026 /PRNewswire/ -- 3Shape, a global innovator in digital dentistry with market-leading intraoral (IOS) scanners, has received this year's 2026 Red Dot Award for its TRIOS MOVE Pro Scanner Cart. The Red Dot Jury posted the following statement: 'The system architectu...
2026-07-27 16:21
1097
Jiangxi Bio's Veterinary Tetanus Antitoxin Production Line Officially Commenced Production,Accelerating Commercialization of the Animal Antiserum Portfolio
HONG KONG, July 27, 2026 /PRNewswire/ -- Jiangxi Institute of Biological Products Inc. and its subsidiaries (collectively, "Jiangxi Bio" or the "Group") (stock code: 6915.HK) is pleased to announce that the veterinary tetanus antitoxin ("Veterinary TAT") production line of Chifeng Bo-en Pharmaceu...
2026-07-27 15:36
3771
Week's Top Stories
Most Reposted
MetaOptics Sharpens Focus on Metalens Commercialisation; Withdraws Nasdaq Listing Application, and Defers U.S. Dual Listing Plan
[Picked up by 313 media titles]
2026-08-07 22:30Agoda Launches AI-Powered Room Grid Bot to Help Travelers Decide Which Room to Book
[Picked up by 313 media titles]
2026-08-13 12:00
GCash Parent Mynt Cited as Sole Philippine Firm in World's Top Fintech Companies List
[Picked up by 296 media titles]
2026-08-12 16:02
Appier Delivers Record-High Revenue, Profitability and Core Free Cash Flow
[Picked up by 295 media titles]
2026-08-13 23:42Two CityUHK scholars elected to the European Academy of Engineering in recognition of their internationally acclaimed research achievements
[Picked up by 294 media titles]
2026-08-10 19:12
Most Read
AMTD IDEA's Receipt of NYSE Letter Regarding ADS Trading Price's Below Compliance Standards
2026-08-08 04:01
16833
China Yuchai International Announces Unaudited 2026 First Half-Year Financial Results
2026-08-07 18:00
16606